Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
Inovio Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 11, 2024
Inovio Pharmaceuticals reported fiscal year 2023 executive compensation information on April 11, 2024.
In 2023, three executives at Inovio Pharmaceuticals received on average a compensation package of $1.6M, a 63% decrease compared to previous year.
Average pay of disclosed executives at Inovio Pharmaceuticals
Jacqueline E. Shea, Chief Executive Officer, received $2.4M in total, which decreased by 31% compared to 2022. 33% of Shea's compensation, or $813K, was in option awards. Shea also received $371K in non-equity incentive plan, $751K in salary, $492K in stock awards, as well as $12K in other compensation.
Peter D. Kies, Chief Financial Officer, received a compensation package of $1.2M, which decreased by 28% compared to previous year. 54% of the compensation package, or $623K, was in salary.
Laurent M. Humeau, Chief Scientific Officer, earned $1.1M in 2023, a 27% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 11, 2024.